Urol. praxi. 2021;22(1):44-46 | DOI: 10.36290/uro.2020.034

Cyst of ejakulary duct, obstructive cause of anejaculation and prostatodynia

MUDr. David Čapka, MUDr. Otakar Štanc, MUDr. Robert Grill
Urologická klinika 3. LF UK v Praze a FNKV, Praha

Prostate cancer is the most common neoplasm in male population. Despite radical therapy in signifiant number of patients recurrence occures. The recurrence is indicated by PSA level elevation. However for adequate treatment setup localisation of site of reccurece is essential. Fluciclovine is radiotracer used for PET imaging. It is well accumulated in prostate cancer cells. Therefore fluciclovine PET/CT stands for sensititive reccurence localisation method in patients suffering from prostate cancer. In this paper we summarize the use of fluciclovine PET/CT in recurrent prostate cancer patients.

Keywords: obstructive azoospermia, ductal system, ejaculatory ductus, cyst.

Received: July 16, 2020; Revised: July 23, 2020; Accepted: July 27, 2020; Prepublished online: July 27, 2020; Published: April 15, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čapka D, Štanc O, Grill R. Cyst of ejakulary duct, obstructive cause of anejaculation and prostatodynia. Urol. praxi. 2021;22(1):44-46. doi: 10.36290/uro.2020.034.
Download citation

References

  1. Pryor JP, Hendry WF. Ejaculatory duct obstruction in subfertile males: analysis of 87 patients. Fertil Steril 1991; 56: 725-730. Go to original source... Go to PubMed...
  2. Goldwasser BZ, Weinerth JL, Carson CC 3rd. Ejaculatory duct obstruction: the case for aggressive diagnosis and treatment. J Urol. 1985; 134: 964-966. Go to original source... Go to PubMed...
  3. Cocuzza M, Alvarenga C, Pagani R. The epidemiology and etiology of azoospermia. Clinics 2013; 68(S1): 15-26. Go to original source... Go to PubMed...
  4. Fisch H, Kang YM, Johnson CW, et al. Ejaculatory duct obstruction. Curr Opin Urol 2002; 12: 509-515. Go to original source... Go to PubMed...
  5. Paick JS, Kim SH, Kim SW. Ejaculatory duct obstruction in infertile men. BJU Int 2000; 85: 720-724. Go to original source... Go to PubMed...
  6. Kuligowska E, Baker CE, Oates RD. Male infertility: role of transrectal US in diagnosis and management. Radiology 1992; 185: 353-360. Go to original source... Go to PubMed...
  7. Baker K, Sabanegh E. Obstructive azoospermia: reconstructive techniques and results. Clinics 2013; 68(S1): 61-73. Go to original source... Go to PubMed...
  8. Cornud F, Belin X, Delafontaine D, et al. Imaging of obstructive azoospermia. Eur Radiol 1997; 7: 1079-1085. Go to original source... Go to PubMed...
  9. Sinha S, Siriguri RS, Rayudu RS. Simultaneous Computed Tomography and Seminal Vesiculography in a Patient With Ejaculatory Duct Obstruction. Urol J 2010; 7: 79. Go to PubMed...
  10. Jarow PJ. Transrectal Ultrasonography in the Diagnosis and Management of Ejaculatory. Journal of Andrology 1996; 17: 467-472. Go to PubMed...
  11. Goluboff ET, Kaplan SA, Fisch H. Seminal vesicle urinary reflux as a complication of transurethral resection of the ejaculatory ducts. J Urol 1995; 153: 1234-1235. Go to original source... Go to PubMed...
  12. Jarow PJ. Transrectal Ultrasonography in the Diagnosis and Management of Ejaculatory. Journal of Andrology 1996; 17: 467-472. Go to PubMed...
  13. Christopher WJ, Jonathan BB, et al. Transurethral resection of the ejaculatory ducts for treating ejaculatory symptoms. BJU Int 2005; 95: 117-119. Go to original source... Go to PubMed...
  14. Baker K, Sabanegh E. Obstructive azoospermia: reconstructive techniques and results. Clinics 2013; 68(S1): 61-73. Go to original source... Go to PubMed...
  15. Hradec T, Zámečník L. Cystická obstrukce ejakulatorního duktu jako příčina azoospermie. Ces Urol 2018: 75-75.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.